Velcade indicated in mantle cell lymphoma

The antineoplastic agent is also indicated in the treatment of multiple myeloma  | SCIENCE PHOTO LIBRARY
The antineoplastic agent is also indicated in the treatment of multiple myeloma | SCIENCE PHOTO LIBRARY
Velcade (bortezomib) can now be used, in combination with rituximab, cyclophosphamide, doxorubicin and prednisolone, for the treatment of adults with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation. 
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more